New cancer vaccine boosts survival rate, Moderna says – CBS News
There is promising news about a potential melanoma vaccine made by Moderna and Merck. Moderna said a small study showed the vaccine significantly reduced patients’ risk of relapse or death. A larger study is planned for next year.
Be the first to know
Receive browser notifications for breaking news, live events, and exclusive reports.